Zobrazeno 1 - 10 of 105 pro vyhledávání: '"E T, Krementz"'
2
Multiple perfusions for melanoma
Autor: E T, Krementz, J H, Muchmore, R D, Carter, C M, Sutherland
Publikováno v: Melanoma research. 4
From 1957 to 1992, 1139 patients had regional perfusion alone, or combined with excisional surgery for malignant melanoma. Of these, 158 patients had multiple perfusions for recurrent disease, including 155 for limb melanoma and three for head and ne
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::16a373802b641541c4c8b0f75e3edcd4
https://pubmed.ncbi.nlm.nih.gov/8038595
Zobrazit plný text záznamu
3
Adoptive immunotherapy of advanced renal cell cancer using PHA-stimulated autologous lymphocytes
Autor: L R, Morgan, E T, Krementz, S W, Fan, D, Fan
Publikováno v: Anticancer research. 13(5C)
Patients with advanced renal cell carcinoma, previously failed maximal treatment with standard chemo-hormonal-radiation therapies, were treated with plant lectin phytohemagglutinin (PHA)-stimulated autologous peripheral blood lymphocytes in a 10-year
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::70c2aaba728d67bab2f074f4f22562b5
https://pubmed.ncbi.nlm.nih.gov/8267379
Zobrazit plný text záznamu
4
Regional perfusion for the treatment of subungual melanoma
Autor: J H, Muchmore, E T, Krementz, R D, Carter, C M, Sutherland, R S, Godfrey
Publikováno v: The American surgeon. 56(2)
Thirty-one patients with subungual melanoma representing 2.6 per cent of all patients with limb melanoma were treated by isolated regional perfusion. Acral lentiginous melanoma prevalent on subungual and volar skin was the most common histologic type
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8b5dd2b05259965c7bec29100ce2266b
https://pubmed.ncbi.nlm.nih.gov/2306053
Zobrazit plný text záznamu
6
A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma
Autor: E T Krementz, K Cartwright, J H Doroshow, I Schoch, Hyman B. Muss, A Reisman, S Wolff, John M. Bennett, G Dukart
Publikováno v: Journal of Clinical Oncology. 6:1611-1620
Three hundred thirty-one women with metastatic breast cancer were randomized to receive combination chemotherapy with either cyclophosphamide, Novantrone (mitoxantrone; Lederle Laboratories, Wayne, NJ), and fluorouracil (CNF) or cyclophosphamide, Adr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e6ceb625e9ab543f59e834ddad1793c
https://doi.org/10.1200/jco.1988.6.10.1611
Zobrazit plný text záznamu
9
Macrophage-Mediated Destruction of Human Malignant Cells In Vivo2
Autor: P. W. A. Mansell, H. Ichinose, R. McNamee, E. T. Krementz, N. R. Di Luzio, R. J. Reed
Publikováno v: JNCI: Journal of the National Cancer Institute.
Macrophages require a plasma component, designated "recognition factor" (RF), for the expression of optimal function. The RF activity was profoundly depleted in plasma from patients with malignant disease, and the degree of depletion and the severity
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d93357c584a9cf5bbde09b001af0c1bd
https://doi.org/10.1093/jnci/54.3.571
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje